Annals of Oncology 6:571-574, 1995
© 1995 European Society for Medical Oncology
research-article |
Central nervous system metastases in patients with ovarian carcinoma
1Department Clinica Ostetrica e Ginecologica-Università degli Studi di Milano, Istituto di Scienze Biomediche, Ospedale S. Cerardo, Monza
2Patologia Ostetrica e Ginecologica-Universita degli Studi di Ban Italy
Correspondence to: Andrea Maneo, M.D. Ostetricia e Ginecologia Ospedale S. Gerardo Via Solferino 16 20052 Monza (Milano) Italy
BACKGROUND: Central nervous system (CNS) involvement by ovarian carcinoma is rare.
PATIENTS AND METHODS: From September 1982 to September 1994, 23 patients with CNS metastases from ovarian carcinoma were observed in our institution.
RESULTS: Their median age at the time of CNS metastasis diagnosis was 59 years, and the median interval between diagnosis of ovarian cancer and documentation of the metastasis was 35 months. The most common symptoms related to CNS involvement were motor weakness, headache, seizures, dizziness and visual disturbances. One patient had meningeal carcinomatosis; 22 had parenchyma] lesions (18 cerebral and 4 cerebellar). Nine patients had a single CNS lesion, and 13 had multiple metastatic sites. CNS was the only site of disease in 9 patients, while 8 had concomitant extra-peritoneal dissemination. The median survival (MS) from diagnosis of cerebral metastases for the entire series was five months. Four patients were not treated (MS 3 months); 14 received radiotherapy (MS 5.5 months), and five underwent surgical resection of solitary metastases followed by radiotherapy (MS 17 months). Number of CNS lesions, extent of the disease at the time of CNS metastasis and treatment were the only factors which significantly affected survival.
CONCLUSIONS: The prognosis of patients with CNS metastasis from ovarian carcinoma appears poor. However, early diagnosis followed by multimodal treatment may result in significant palliation and improve overall survival in a selected group of patients.
central nervous system metastasis, ovarian carcinoma
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Belotti, C. Calcagno, A. Garofalo, D. Caronia, E. Riccardi, R. Giavazzi, and G. Taraboletti Vascular Endothelial Growth Factor Stimulates Organ-Specific Host Matrix Metalloproteinase-9 Expression and Ovarian Cancer Invasion Mol. Cancer Res., April 1, 2008; 6(4): 525 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pectasides, M. Pectasides, and T. Economopoulos Brain metastases from epithelial ovarian cancer: a review of the literature. Oncologist, March 1, 2006; 11(3): 252 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Atallah, G. Chahine, and I. A. Voutsadakis Uncommon Presentations of Malignancies: CASE 3. BRAIN METASTASIS FROM OVARIAN CANCER J. Clin. Oncol., August 1, 2003; 21(15): 2996 - 2998. [Full Text] [PDF] |
||||
![]() |
D. F. Kolomainen, J. M.G. Larkin, M. Badran, R. P. A'Hern, D. M. King, C. Fisher, J. E. Bridges, P. R. Blake, D. P.J. Barton, J. H. Shepherd, et al. Epithelial Ovarian Cancer Metastasizing to the Brain: A Late Manifestation of the Disease With an Increasing Incidence J. Clin. Oncol., February 15, 2002; 20(4): 982 - 986. [Abstract] [Full Text] [PDF] |
||||


